Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 18 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

pembrolizumab 2 Nivolumab 2 Ipilimumab 2 Exercise 2 cemiplimab 1 avelumab 1 Psychology, Positive 1 Methods 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Diet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Motor Activity × Immunotherapy × Dermatologic × Clear all

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡